Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Empagliflozin 10 vs 25 mg on LV Remodeling in Diabetic Patients With Anterior STEMI With Reduced LVEF Who Underwent Primary PCI

NCT07169981 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07169981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07169981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Empagliflozin 10 vs 25 mg on LV Remodeling in Diabetic Patients With Anterior STEMI With Reduced LVEF Who Underwent Primary PCI
Lead sponsor
Ain Shams University
Phase
Phase 2
Overall status
Completed
Start date
July 12, 2023
Completion date
June 17, 2025
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabete mellitus, heart failure, remodeling, left ventricle